S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Elon Musk May Have Just Changed Everything (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
BREAKING: The truth about war with China (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Elon Musk May Have Just Changed Everything (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
BREAKING: The truth about war with China (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Elon Musk May Have Just Changed Everything (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
BREAKING: The truth about war with China (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
Elon Musk May Have Just Changed Everything (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
BREAKING: The truth about war with China (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds an annual oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
NASDAQ:APTO

Aptose Biosciences (APTO) Earnings Date, Estimates & Call Transcripts

$2.80
+0.04 (+1.45%)
(As of 09/29/2023 08:52 PM ET)
Compare
Today's Range
$2.78
▼
$2.91
50-Day Range
$2.76
▼
$5.04
52-Week Range
$2.76
▼
$11.85
Volume
44,800 shs
Average Volume
27,666 shs
Market Capitalization
$20.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$38.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 7Estimated
Actual EPS
(Aug. 10)
-$2.27 Missed By -$0.18
Consensus EPS
(Aug. 10)
-$2.09
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

APTO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

APTO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aptose Biosciences Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20232($0.16)($0.12)($0.14)
Q2 20233($2.29)($0.12)($0.86)
Q3 20233($1.29)($0.10)($0.52)
Q4 20233($1.43)($0.10)($0.57)
FY 202311($5.17)($0.44)($2.10)

APTO Earnings Date and Information

Aptose Biosciences last issued its quarterly earnings results on August 10th, 2023. The biotechnology company reported ($2.27) earnings per share for the quarter, missing analysts' consensus estimates of ($2.09) by $0.18. Aptose Biosciences has generated ($7.82) earnings per share over the last year (($7.82) diluted earnings per share). Earnings for Aptose Biosciences are expected to grow in the coming year, from ($8.65) to ($7.14) per share. Aptose Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 7th, 2023 based off prior year's report dates.

Aptose Biosciences Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/7/2023
Estimated)		------- 
8/10/2023Q2 2023($2.09)($2.27)($0.18)($2.27)--
5/8/2023Q1 2023($1.80)($2.25)($0.45)($2.25)--
3/23/2023Q4 2022($1.65)($1.65)-($0.11)--    
11/1/2022Q3 2022($1.80)($1.65)+$0.15($0.11)--
8/2/2022Q2 2022($1.95)($1.65)+$0.30($0.11)--
5/9/2022Q1 2022($2.25)($1.80)+$0.45($0.12)--    
3/22/2022Q4 2021($2.70)($4.05)($1.35)($0.27)--    
11/11/2021Q3 2021($2.55)($1.95)+$0.60($0.13)--    
8/2/2021Q2 2021($2.85)($2.25)+$0.60($0.15)--    
5/4/2021Q1 2021($2.55)($2.70)($0.15)($0.18)--  
3/22/2021Q4 2020($2.55)($2.40)+$0.15($0.17)--  
11/15/2020Q3($2.70)($2.25)+$0.45($0.15)--  












Aptose Biosciences Earnings - Frequently Asked Questions

When is Aptose Biosciences's earnings date?

Aptose Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 7th, 2023 based off last year's report dates. Learn more on APTO's earnings history.

Did Aptose Biosciences beat their earnings estimates last quarter?

In the previous quarter, Aptose Biosciences (NASDAQ:APTO) missed the analysts' consensus estimate of ($2.09) by $0.18 with a reported earnings per share (EPS) of ($2.27). Learn more on analysts' earnings estimate vs. APTO's actual earnings.

How much profit does Aptose Biosciences generate each year?

Aptose Biosciences (NASDAQ:APTO) has a recorded net income of -$41.82 million. APTO has generated -$7.82 earnings per share over the last four quarters.

What is Aptose Biosciences's EPS forecast for next year?

Aptose Biosciences's earnings are expected to grow from ($8.65) per share to ($7.14) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:APTO) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -